1. Home
  2. JSPRW vs EPRT Comparison

JSPRW vs EPRT Comparison

Compare JSPRW & EPRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JSPRW
  • EPRT
  • Stock Information
  • Founded
  • JSPRW N/A
  • EPRT 2016
  • Country
  • JSPRW United States
  • EPRT United States
  • Employees
  • JSPRW 45
  • EPRT N/A
  • Industry
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • EPRT Real Estate Investment Trusts
  • Sector
  • JSPRW Health Care
  • EPRT Real Estate
  • Exchange
  • JSPRW Nasdaq
  • EPRT Nasdaq
  • Market Cap
  • JSPRW N/A
  • EPRT N/A
  • IPO Year
  • JSPRW 2020
  • EPRT 2018
  • Fundamental
  • Price
  • JSPRW $0.22
  • EPRT $31.73
  • Analyst Decision
  • JSPRW
  • EPRT Strong Buy
  • Analyst Count
  • JSPRW 0
  • EPRT 16
  • Target Price
  • JSPRW N/A
  • EPRT $33.92
  • AVG Volume (30 Days)
  • JSPRW N/A
  • EPRT 959.8K
  • Earning Date
  • JSPRW N/A
  • EPRT 02-12-2025
  • Dividend Yield
  • JSPRW N/A
  • EPRT 3.64%
  • EPS Growth
  • JSPRW N/A
  • EPRT N/A
  • EPS
  • JSPRW N/A
  • EPRT 1.15
  • Revenue
  • JSPRW N/A
  • EPRT $428,535,000.00
  • Revenue This Year
  • JSPRW N/A
  • EPRT N/A
  • Revenue Next Year
  • JSPRW N/A
  • EPRT $18.79
  • P/E Ratio
  • JSPRW N/A
  • EPRT $27.43
  • Revenue Growth
  • JSPRW N/A
  • EPRT 27.83
  • 52 Week Low
  • JSPRW N/A
  • EPRT $23.58
  • 52 Week High
  • JSPRW N/A
  • EPRT $34.88
  • Technical
  • Relative Strength Index (RSI)
  • JSPRW N/A
  • EPRT 45.45
  • Support Level
  • JSPRW N/A
  • EPRT $32.54
  • Resistance Level
  • JSPRW N/A
  • EPRT $33.05
  • Average True Range (ATR)
  • JSPRW 0.00
  • EPRT 0.53
  • MACD
  • JSPRW 0.00
  • EPRT -0.07
  • Stochastic Oscillator
  • JSPRW 0.00
  • EPRT 14.46

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: